Identification of Drug Combinations Containing Imatinib for Treatment of BCR-ABL+ Leukemias

Open Access

Peer-reviewed

Research Article

Yunyi Kang,

Affiliation Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America
⨯
Andrew Hodges,

Affiliation Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America
⨯
Edison Ong,

Affiliation Salgomed Inc., Del Mar, California, United States of America
⨯
William Roberts,

Affiliation Rady Children's Hospital, Department of Pediatrics, University of California San Diego, San Diego, California, United States of America
⨯
Carlo Piermarocchi,

Affiliation Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan, United States of America
⨯
Giovanni Paternostro

* E-mail: giovanni@burnham.org

Affiliation Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America
⨯

Reader Comments (0)

Library screening
Is the Subject Area "Library screening" applicable to this article?

Thanks for your feedback.
Kinase inhibitors
Is the Subject Area "Kinase inhibitors" applicable to this article?

Thanks for your feedback.
Leukemia
Is the Subject Area "Leukemia" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Algorithms
Is the Subject Area "Algorithms" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.